SCHEMBL22037598

SCHEMBL22037598

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5cccc6c5-c5ccccc5C6(c5ccccc5)c5ccccc5)cc4)cc(-c4cccnc4)n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 7/20 0.47
CYP19A1 P11511 1/20 0.45
DHODH Q02127 1/20 0.40
ALDH1A1 P00352 5/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
HPGD P15428 3/20 0.37
NTSR1 P30989 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
KDM4E B2RXH2 3/20 0.37
GLA P06280 2/20 0.37
GAA P10253 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
VCP P55072 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22037438 0.98 PDK2 (0.45) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22038471 0.98 PDK2 (0.45) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22037624 0.98 PDK2 (0.45) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22038366 0.96 PDK2 (0.46) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22037930 0.95 PDK2 (0.46) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22037481 0.94 PDK2 (0.43) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22038352 0.94 PDK2 (0.43) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22038047 0.94 PDK2 (0.43) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22039018 0.94 PDK2 (0.45) PDK2CYP19A1DHODHALDH1A1LMNA
SCHEMBL22227772 0.93 PDK2 (0.48) PDK2CYP19A1DHODHALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 PDK2 2857/4885CYP19A1 1838/4885DHODH 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.